Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
47Activity
0 of .
Results for:
No results containing your search query
P. 1
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players

Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players

Ratings: (0)|Views: 585|Likes:
Published by Giovanny Leon
The pharma industry is affected by the dynamic shifts in the
market. New revenue models are resulting from activities such
as parallel trade, the generic vs. patent fight, mergers and
acquisitions (M&A), in-licensing and out-licensing, and the
choice between semi block buster and block buster. The shift
from chemical-based small molecules to biology-based large
molecules like antibodies and protein has also created new
opportunities in the industry.
The pharma industry is affected by the dynamic shifts in the
market. New revenue models are resulting from activities such
as parallel trade, the generic vs. patent fight, mergers and
acquisitions (M&A), in-licensing and out-licensing, and the
choice between semi block buster and block buster. The shift
from chemical-based small molecules to biology-based large
molecules like antibodies and protein has also created new
opportunities in the industry.

More info:

Published by: Giovanny Leon on Mar 12, 2010
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

12/07/2010

pdf

text

original

 
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players
1
Emerging Business Modelsin the Pharmaceutical IndustriesStrategic Analysis of the Pharma Market, FutureRevenue Models and Key Players
JSB Intelligence
Kildare House, 102-104 Sheen RoadRichmond, TW9 1UF, UKTel. +44 (0) 870 7653 632Fax. +44 (0) 870 7653 722Email: pharma@jsbintelligence.com
 
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players
2
“Personalised medicine is a laudable aim, but we are not anywherenear there yet…I think biotech has investigated some niche disease areas with targeted approaches. But it is in the early days.” -Dr. Declan P. Doogan, head of medical and development science, Pfizer Inc.
 
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players
3
Table of Contents
Introduction……………………………………………..….……………………….
Market Structure and Overview………………………………………………….
Factors Increasing Market Size…………………………………………
Market Restraints………………………………………………………….
Dynamic Shifts in Pharma Market …..…………………………………
Geographic Overview & Landscaping…………………………………
Trends……………………………………………………………………………..
Long Term Strategies
Long Term Strategies -Forward Integration Model…………………
Long Term Strategies -Targeted Treatment Solutions……………….
Long Term Strategies -Biotech and Genomics………………………
Network Model
Network Model -Outsourcing…………………………………………
Network Model -In-licensing vs. Out-licensing…………………………
Network Model -Product Life Cycle Management……………………
Short Term Strategies
Short Term Strategies -Semi Block Buster Model…………………….
Short Term Strategies -Pre-and Post-patent Based ……………….
Short Term Strategies Against Parallel Trade…………………………
Mergers & Acquisitions………………………………………………………….
Market Forecasting & New Revenue Models………………………………….
The Winning Proposition…………………………………………………………691112131517192123273031323437394144

Activity (47)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
cbdmt liked this
jaberjoumana9683 liked this
priyaa2688 liked this
priyaa2688 liked this
nisarg dave liked this
nisarg dave liked this
ricktimmer liked this
shashi967 liked this

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->